Phase
Condition
Oral Facial Pain
Migraine And Cluster Headaches
Migraine (Pediatric)
Treatment
PRIMUS
Clinical Study ID
Ages 18-84 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of migraine as defined by the ICHD-3 Classification (with or without aura)with a history of chronic or high-frequency episodic migraine for at least 1 yearprior to screening
Failure of 3 or more preventive pharmacological therapies
Stable on preventive migraine treatments
Psychologically stable
Exclusion
Exclusion Criteria:
Concomitant invasive or non-invasive neuromodulation
Previous exposure to an implantable neuromodulation device for headache
Have an existing active implantable medical device nearby the implant location (e.g.DBS, cochlear implant)
Use of onabotulinum toxin A injections for the treatment of migraine in the past 3months.
Use of steroid infiltrations or IV administration in the past 3 months.
Not pregnant, nursing or not using contraception
Study Design
Connect with a study center
Genesis Research Services
Broadmeadow, New South Wales NSW, 2292
AustraliaActive - Recruiting
Resolve Pain
Buderim, Queensland 4556
AustraliaActive - Recruiting
Monash House Private Hospital
Clayton, Victoria VIC, 3168
AustraliaSite Not Available
Jessa Hasselt
Hasselt, Limburg 3500
BelgiumActive - Recruiting
AZ Sint Jan Brugge
Brugge, West Vlaanderen 8000
BelgiumActive - Recruiting
AZ Delta
Roeselare,
BelgiumActive - Recruiting
GZA Ziekenhuizen
Wilrijk,
BelgiumSite Not Available
ZAS Antwerpen, Campus Sint-Augustinus
Wilrijk,
BelgiumActive - Recruiting
St. Antonius Nieuwegein
Nieuwegein,
NetherlandsActive - Recruiting
Erasmus MC Rotterdam
Rotterdam,
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.